von Stechow Dietrich, Rauschmann M A
Department of Orthopaedic Surgery, University Hospital, Frankfurt/Main, Germany.
Eur Surg Res. 2009;43(3):298-305. doi: 10.1159/000233525. Epub 2009 Aug 13.
Degradable composites of calcium sulphate and nanoparticulate hydroxyapatite (PerOssal) have shown promising results in vitro. Here we investigated the handling, efficacy and compatibility of PerOssal when loaded with gentamicin or vancomycin in 19 patients with spondylodiscitis in vivo. So far, 12 patients who were followed up over at least 1 year have shown a normalization of the infection parameters, no more bone loss in the affected regions and a bony fusion after 3-6 months postoperatively. No revision surgery was related to the use of PerOssal. Locally there were no signs of an ongoing infection. This study demonstrates encouraging results regarding handling, resorption, biocompatibility and antibiotic release using PerOssal pellets in vivo.
硫酸钙与纳米颗粒羟基磷灰石的可降解复合材料(PerOssal)在体外已显示出有前景的结果。在此,我们在19例脊椎椎间盘炎患者体内研究了负载庆大霉素或万古霉素的PerOssal的操作、疗效及兼容性。到目前为止,12例接受至少1年随访的患者感染参数已恢复正常,患区无骨质进一步流失,术后3 - 6个月实现了骨融合。没有翻修手术与使用PerOssal相关。局部没有持续感染的迹象。这项研究证明了在体内使用PerOssal颗粒在操作、吸收、生物相容性及抗生素释放方面取得了令人鼓舞的结果。